Re-engineering islet cell transplantation

Nicoletta Fotino, Carmen Fotino, Antonello Pileggi

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


We are living exciting times in the field of beta cell replacement therapies for the treatment of diabetes. While steady progress has been recorded thus far in clinical islet transplantation, novel approaches are needed to make cell-based therapies more reproducible and leading to long-lasting success. The multiple facets of diabetes impose the need for a transdisciplinary approach to attain this goal, by targeting immunity, promoting engraftment and sustained functional potency. We discuss herein the emerging technologies applied to this rapidly evolving field.

Original languageEnglish (US)
Pages (from-to)76-85
Number of pages10
JournalPharmacological Research
StatePublished - Jun 12 2015


  • Beta cells
  • Biomaterials
  • Cellular therapies
  • Diabetes
  • Implantable devices
  • Insulin
  • Islet transplantation
  • Islets of Langerhans
  • Stem cells
  • Tissue engineering

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Re-engineering islet cell transplantation'. Together they form a unique fingerprint.

Cite this